Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ladoire

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Molecular Medicine|May 17, 2011
Restoration of antitumor immunity through selective inhibition of myeloid derived suppressor cells by anticancer therapiesL Apetoh, F Végran, S Ladoire, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2015
Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?L Apetoh, S Ladoire, G Coukos, et al.
Oncogene|May 26, 2010
Human FOXP3 and cancerF Martin, S Ladoire, G Mignot, et al.
La Revue De Medecine Interne|March 22, 2005
[Treatment of cancer and hematological malignancy in elderly people: oncogeriatrics as a discipline for the future (Part I): geriatric evaluation and management of solid tumors]F Ghiringhelli, S Ladoire, P Manckoundia, et al.
La Revue De Medecine Interne|April 12, 2005
[Treatment of cancer and hematological malignancy in elderly people (Part II)]S Ladoire, F Ghiringhelli, P Manckoundia, et al.
British Journal of Cancer|July 14, 2011
T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survivalS Ladoire, L Arnould, G Mignot, et al.
British Journal of Cancer|October 28, 2010
Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancerS Guiu, M Gauthier, B Coudert, et al.
Oncoimmunology|February 6, 2018
Tumor lymphocyte immune response to preoperative radiotherapy in locally advanced rectal cancer: The LYMPHOREC studyC Mirjolet, C Charon-Barra, S Ladoire, et al.
Cell Death and Differentiation|July 2, 2013
Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonistsT Yamazaki, D Hannani, V Poirier-Colame, et al.
Cell Death and Differentiation|August 16, 2014
Liver X receptor β activation induces pyroptosis of human and murine colon cancer cellsV Derangère, A Chevriaux, F Courtaut, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Molecular Medicine|May 17, 2011
Restoration of antitumor immunity through selective inhibition of myeloid derived suppressor cells by anticancer therapiesL Apetoh, F Végran, S Ladoire, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2015
Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?L Apetoh, S Ladoire, G Coukos, et al.
Oncogene|May 26, 2010
Human FOXP3 and cancerF Martin, S Ladoire, G Mignot, et al.
La Revue De Medecine Interne|March 22, 2005
[Treatment of cancer and hematological malignancy in elderly people: oncogeriatrics as a discipline for the future (Part I): geriatric evaluation and management of solid tumors]F Ghiringhelli, S Ladoire, P Manckoundia, et al.
La Revue De Medecine Interne|April 12, 2005
[Treatment of cancer and hematological malignancy in elderly people (Part II)]S Ladoire, F Ghiringhelli, P Manckoundia, et al.
British Journal of Cancer|July 14, 2011
T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survivalS Ladoire, L Arnould, G Mignot, et al.
British Journal of Cancer|October 28, 2010
Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancerS Guiu, M Gauthier, B Coudert, et al.
Oncoimmunology|February 6, 2018
Tumor lymphocyte immune response to preoperative radiotherapy in locally advanced rectal cancer: The LYMPHOREC studyC Mirjolet, C Charon-Barra, S Ladoire, et al.
Cell Death and Differentiation|July 2, 2013
Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonistsT Yamazaki, D Hannani, V Poirier-Colame, et al.
Cell Death and Differentiation|August 16, 2014
Liver X receptor β activation induces pyroptosis of human and murine colon cancer cellsV Derangère, A Chevriaux, F Courtaut, et al.
Pageof 2